Related Experiment Video
Updated: Sep 20, 2025
A New Ex Vivo Model for the Evaluation of Endoscopic Submucosal Injection Material Performance
Published on: October 19, 2018
Hydrogels in endoscopic submucosal dissection for gastrointestinal cancers
Mengdan Xu1, Keyang Xu1, Wei Peng2
1Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education Institutions, Center for Molecular Imaging and Nuclear Medicine, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Soochow University, Suzhou 215123, China.
Hydrogels offer improved mucosal elevation and wound healing for endoscopic submucosal dissection (ESD) in gastrointestinal cancers. This review explores hydrogel applications to minimize complications and enhance patient recovery in ESD procedures.
Area of Science:
- Gastroenterology
- Biomaterials Science
- Minimally Invasive Surgery
Background:
- Endoscopic Submucosal Dissection (ESD) is a key technique for early gastrointestinal cancers.
- Current submucosal injection materials for ESD have limitations like rapid diffusion and inflammation.
- There is a need for improved biomaterials to enhance ESD outcomes and patient recovery.
Purpose of the Study:
- To review the development and application of hydrogels in ESD.
- To analyze hydrogels' physicochemical properties, biocompatibility, and clinical implications.
- To explore innovations and future directions for hydrogels in ESD.
Main Methods:
- Comprehensive literature review of hydrogel technologies in ESD.
- Analysis of hydrogel formulations, mechanisms of action, and comparative studies.
- Examination of clinical implications and patient outcomes associated with hydrogel use.
Main Results:
- Hydrogels demonstrate potential for sustained mucosal elevation, crucial for ESD.
- Hydrogels exhibit favorable biocompatibility and can support wound healing processes.
- Comparative analyses suggest hydrogels may outperform traditional submucosal injection materials.
Conclusions:
- Hydrogels represent a promising advancement in submucosal injection materials for ESD.
- Optimized hydrogels can potentially reduce postoperative complications and improve patient recovery.
- Further research into hydrogel innovation is essential for advancing ESD techniques in gastrointestinal cancer treatment.
